Related Experiment Videos
Efficacy of hyperbaric oxygenation in atopic dermatitis
R Olszański1, M Pachut, Z Sićko
1Institute of Maritime Medicine at the Military Medical Academy, Gdynia.
Bulletin of the Institute of Maritime and Tropical Medicine in Gdynia
|January 1, 1992
Summary
Hyperbaric oxygen therapy improved symptoms in patients with atopic dermatitis and asthma-prurigo. This treatment also led to decreased immunoglobulin E and complement levels in most participants.
Area of Science:
- Dermatology
- Immunology
- Hyperbaric Medicine
Background:
- Atopic dermatitis and asthma-prurigo are inflammatory skin conditions often associated with elevated immunoglobulin E (IgE) and complement levels.
- Current treatments may have limitations, necessitating exploration of novel therapeutic approaches.
Purpose of the Study:
- To evaluate the clinical efficacy of hyperbaric oxygenation (HBO) in patients with atopic dermatitis and asthma-prurigo.
- To assess the impact of HBO on immunoglobulin (IgG, IgM, IgE) and complement (C3, C4) levels in these patients.
Main Methods:
- Ten patients (5 with atopic dermatitis, 5 with asthma-prurigo), aged 8-38 years, underwent daily hyperbaric oxygenation at 0.1 MPa pure oxygen for 15 days.
- Clinical evaluations were performed alongside parallel measurements of serum IgG, IgM, IgE, C3, and C4 levels.
Main Results:
- All ten patients demonstrated clinical improvement following hyperbaric oxygenation therapy.
- A significant decrease in immunoglobulin E (IgE) levels was observed in 9 out of 10 patients.
- Decreased levels of C3 and C4 complement components were also noted post-treatment.
Conclusions:
- Hyperbaric oxygenation shows promise as an effective treatment modality for atopic dermatitis and asthma-prurigo.
- HBO therapy may modulate immune responses by reducing IgE and complement levels, contributing to clinical improvement.